{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:31:53Z","timestamp":1790069513320,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572567"],"award-info":[{"award-number":["81572567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313656"],"award-info":[{"award-number":["2017A030313656"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation","award":["pdjh2017b0014"],"award-info":[{"award-number":["pdjh2017b0014"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bcp.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T22:06:06Z","timestamp":1547157966000},"page":"98-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes"],"prefix":"10.1016","volume":"161","author":[{"given":"Xiaodi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-462X","authenticated-orcid":false,"given":"Jiancheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2019.01.009_b0005","first-page":"1399","article-title":"The clinicopathologic characteristics and 5-year survival rate of epithelial ovarian cancer in Yazd, Iran","volume":"7","author":"Karimi-Zarchi","year":"2015","journal-title":"Electron. Physician"},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.bcp.2019.01.009_b0015","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","author":"Chen","year":"2016","journal-title":"Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.bcp.2019.01.009_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Yeung","year":"2016","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.bcp.2019.01.009_b0030","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.18632\/oncotarget.2089","article-title":"FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bcp.2019.01.009_b0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2019.01.009_b0040","first-page":"16","article-title":"Analysis of miRNA expression profiles in breast cancer using biclustering","author":"Fiannaca","year":"2015","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"10.1016\/j.bcp.2019.01.009_b0045","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ijc.22394","article-title":"Expression profiling identifies microRNA signature in pancreatic cancer","volume":"120","author":"Lee","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2019.01.009_b0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","article-title":"MicroRNAs: novel regulators in the hallmarks of human cancer","volume":"285","author":"Ruan","year":"2009","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.bcp.2019.01.009_b0055","first-page":"3365","article-title":"MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3","volume":"118","author":"Feng","year":"2012","journal-title":"Cancer-Am. Cancer Soc."},{"issue":"5","key":"10.1016\/j.bcp.2019.01.009_b0060","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00404-015-3713-2","article-title":"miR-31 functions as an oncogene in cervical cancer","volume":"292","author":"Zheng","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3892\/ol.2015.3877","article-title":"Association between the rs11614913 variant of miRNA-196a-2 and the risk of epithelial ovarian cancer","volume":"11","author":"Song","year":"2016","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.bcp.2019.01.009_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136913","article-title":"Generation and Validation of miR-142 Knock Out Mice","volume":"10","author":"Shrestha","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2019.01.009_b0075","doi-asserted-by":"crossref","first-page":"E47","DOI":"10.4103\/0019-509X.172513","article-title":"Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer","volume":"52","author":"Shi","year":"2015","journal-title":"Indian J. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2019.01.009_b0080","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2019.01.009_b0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11684-015-0409-8","article-title":"MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility","volume":"9","author":"Tsang","year":"2015","journal-title":"Front. Med.-PRC"},{"issue":"6","key":"10.1016\/j.bcp.2019.01.009_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002436","article-title":"MicroRNA expression and identification of putative miRNA targets in ovarian cancer","volume":"3","author":"Dahiya","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2019.01.009_b0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.cdd.4400503","article-title":"Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma","volume":"6","author":"Wagenknecht","year":"1999","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bcp.2019.01.009_b0100","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.3892\/ol.2016.4388","article-title":"BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients","volume":"11","author":"Alhourani","year":"2016","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.bcp.2019.01.009_b0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12094-015-1363-2","article-title":"XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro","volume":"18","author":"Fu","year":"2016","journal-title":"Clin. Transl. Oncol."},{"issue":"19","key":"10.1016\/j.bcp.2019.01.009_b0110","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/onc.2012.258","article-title":"MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells","volume":"32","author":"Xie","year":"2013","journal-title":"Oncogene"},{"issue":"11\u201312","key":"10.1016\/j.bcp.2019.01.009_b0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3727\/0965040042707943","article-title":"Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol","volume":"14","author":"Sapi","year":"2004","journal-title":"Oncol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2019.01.009_b0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3892\/or.2014.3698","article-title":"Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin","volume":"33","author":"Qu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2019.01.009_b0125","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ijc.23278","article-title":"Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo","volume":"122","author":"Shaw","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2019.01.009_b0130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1349-7006.2009.01112.x","article-title":"Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells","volume":"100","author":"Karasawa","year":"2009","journal-title":"Cancer Sci."},{"issue":"26","key":"10.1016\/j.bcp.2019.01.009_b0135","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1073\/pnas.1005667107","article-title":"Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression","volume":"107","author":"Petersen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.bcp.2019.01.009_b0140","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/gut.2007.148189","article-title":"Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer","volume":"57","author":"Feldmann","year":"2008","journal-title":"Gut"},{"issue":"22","key":"10.1016\/j.bcp.2019.01.009_b0145","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.81.22.7166","article-title":"A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia","volume":"81","author":"Pegoraro","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5303","key":"10.1016\/j.bcp.2019.01.009_b0150","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","article-title":"Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked","volume":"275","author":"Yang","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.devcel.2011.06.017","article-title":"Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics","volume":"21","author":"Martinou","year":"2011","journal-title":"Dev. Cell"},{"issue":"53","key":"10.1016\/j.bcp.2019.01.009_b0160","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family: roles in cell survival and oncogenesis","volume":"22","author":"Cory","year":"2003","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bcp.2019.01.009_b0165","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"40","key":"10.1016\/j.bcp.2019.01.009_b0170","doi-asserted-by":"crossref","first-page":"37430","DOI":"10.1074\/jbc.M207413200","article-title":"Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and fortilin \u2013 the potential role of MCL1 as a fortilin chaperone","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2019.01.009_b0175","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/onc.2010.559","article-title":"Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"issue":"7354","key":"10.1016\/j.bcp.2019.01.009_b0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature10133","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 (vol 471, pg 110, 2011)","volume":"475","author":"Wertz","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2019.01.009_b0185","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3892\/or.2013.2482","article-title":"miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w","volume":"30","author":"Cao","year":"2013","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.009_b0190","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11596-013-1160-5","article-title":"MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells","volume":"33","author":"Rao","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bjc.2016.379","article-title":"microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP","volume":"116","author":"Li","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3892\/ijo.2017.4023","article-title":"MicroRNA146a5p enhances cisplatininduced apoptosis in ovarian cancer cells by targeting multiple antiapoptotic genes","volume":"51","author":"Li","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2019.01.009_b0205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0210","first-page":"25","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Gene Ontol. Consortium Nat. Genet."},{"issue":"Database issue","key":"10.1016\/j.bcp.2019.01.009_b0215","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","article-title":"KEGG for representation and analysis of molecular networks involving diseases and drugs","volume":"38","author":"Kanehisa","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.bcp.2019.01.009_b0220","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ijc.26044","article-title":"HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation","volume":"130","author":"He","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2019.01.009_b0225","first-page":"1862","article-title":"XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells","volume":"61","author":"Asselin","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cancergencyto.2007.07.021","article-title":"Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population","volume":"180","author":"Kang","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.009_b0235","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/030089161109700222","article-title":"Distribution of coding apoptotic gene polymorphisms in women with extreme phenotypes of breast cancer predisposition and tolerance","volume":"97","author":"Ulybina","year":"2011","journal-title":"Tumori"},{"issue":"7","key":"10.1016\/j.bcp.2019.01.009_b0240","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bcp.2019.01.009_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020363","article-title":"Human MicroRNA targets","volume":"2","author":"John","year":"2004","journal-title":"PLoS Biol."},{"issue":"24","key":"10.1016\/j.bcp.2019.01.009_b0250","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1158\/0008-5472.CAN-08-1954","article-title":"MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.009_b0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2009.01.014","article-title":"MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy","volume":"113","author":"Boren","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bcp.2019.01.009_b0260","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-7-35","article-title":"Potential role of miR-9 and miR-223 in recurrent ovarian cancer","volume":"7","author":"Laios","year":"2008","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2019.01.009_b0265","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2008.08.017","article-title":"Role of microRNAs in drug-resistant ovarian cancer cells","volume":"111","author":"Sorrentino","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2019.01.009_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068204","article-title":"Large-scale screens of miRNA-mRNA interactions unveiled that the 3 ' UTR of a gene is targeted by multiple miRNAs","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"issue":"7353","key":"10.1016\/j.bcp.2019.01.009_b0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2019.01.009_b0280","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1007\/s13277-015-3365-7","article-title":"MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK","volume":"36","author":"Zou","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bcp.2019.01.009_b0285","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01977","article-title":"miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway","volume":"3","author":"Isobe","year":"2014","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2014.12.042","article-title":"The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells","volume":"137","author":"Pink","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"33","key":"10.1016\/j.bcp.2019.01.009_b0295","first-page":"2705","article-title":"Involvement of miR-199a in cisplatin resistance of ovarian cancer cell through modulating expression of mTOR","volume":"95","author":"Wang","year":"2015","journal-title":"Zhonghua yi xue za zhi"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.01.009_b0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.03.006","article-title":"MicroRNAs as prognostic markers in ovarian cancer","volume":"390","author":"Llaurado","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.bcp.2019.01.009_b0305","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ijc.28774","article-title":"miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6","volume":"135","author":"Zhu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2019.01.009_b0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2470-3","article-title":"Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells","volume":"16","author":"Flores-Perez","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2019.01.009_b0315","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.12659\/MSM.894324","article-title":"miR-221 and miR-222 simultaneously target RECK and regulate growth and invasion of gastric cancer cells","volume":"21","author":"Liu","year":"2015","journal-title":"Med. Sci. Monitor"},{"issue":"9","key":"10.1016\/j.bcp.2019.01.009_b0320","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.18632\/oncotarget.7048","article-title":"Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway","volume":"7","author":"Deng","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2019.01.009_b0330","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12032-015-0703-y","article-title":"The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116","volume":"32","author":"Dabkeviciene","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bcp.2019.01.009_b0335","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.136","article-title":"Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation","volume":"5","author":"Cioce","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2019.01.009_b0340","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2016.02.008","article-title":"Role of antibodies in diagnosis and treatment of ovarian cancer: Basic approach and clinical status","volume":"226","author":"Bhatt","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2019.01.009_b0345","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.5604\/17322693.1184451","article-title":"Ovarian cancer \u2013 from biology to clinic","volume":"69","author":"Kujawa","year":"2015","journal-title":"Postepy higieny i medycyny doswiadczalnej"},{"issue":"9","key":"10.1016\/j.bcp.2019.01.009_b0350","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.humpath.2015.06.013","article-title":"MicroRNAs in ovarian cancer","volume":"46","author":"Katz","year":"2015","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.bcp.2019.01.009_b0355","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3892\/or.2014.3640","article-title":"Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer","volume":"33","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2019.01.009_b0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.modgep.2005.05.003","article-title":"Core binding factor in the early avian embryo: cloning of Cbfbeta and combinatorial expression patterns with Runx1","volume":"6","author":"Bollerot","year":"2005","journal-title":"Gene Expression Patterns"},{"key":"10.1016\/j.bcp.2019.01.009_b0365","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS15-P2-03-04","article-title":"Down-regulation of Bcl2-related ovarian killer (BOK) by miR-296-5p protects breast cancer cells from paclitaxel-induced apoptosis","volume":"76","author":"Onyeagucha","year":"2016","journal-title":"Cancer Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:44:59Z","timestamp":1565217899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219300152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":73,"alternative-id":["S0006295219300152"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.01.009","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}